On Friday evening, the far-right United States Court of Appeals for the Fifth Circuit attempted to cut off access to the abortion drug mifepristone . If you’re experiencing déjà vu, you should be, because in 2023, the far-right United States Court of Appeals for the Fifth Circuit also attempted to cut off access to the abortion drug mifepristone . Almost immediately after the Fifth Circuit issued its second decision, two pharmaceutical companies that make the drug asked the Supreme Court to intervene. The two largely identical cases now before the justices are known as Danco Laboratories v. Louisiana and GenBioPro v. Louisiana . SCOTUS, Explained Get the latest developments on the US Supreme Court from senior correspondent Ian Millhiser. The Fifth Circuit’s reasoning the first time around was so weak that the Supreme Court unanimously rejected it , holding that federal courts did not even have jurisdiction to hear the case in the first place.…